Tirzepatide

CAS #: 2023788-19-2

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight: approx. 4,851.07 g/mol

Tirzepatide (Active ingredient in Mounjaro & Zepbound) is a dual agonist that targets two hormones: GLP-1, which helps regulate blood sugar and reduce hunger, and GIP, which also supports insulin secretion. By activating both receptors, tirzepatide is more effective in controlling blood sugar and promoting weight loss compared to medications targeting GLP-1 alone, like semaglutide.

• Superior Blood Sugar Control: Shows stronger reductions in HbA1c (long-term blood sugar levels) compared to semaglutide.
• Greater Weight Loss: Leads to more significant weight loss (up to 22% in some studies) compared to semaglutide, which typically results in 10-15% weight loss.
• Enhanced Appetite Control: Dual receptor activation results in better appetite suppression, contributing to more sustained weight management.
• Improved Insulin Sensitivity: The combination of GLP-1 and GIP action may provide a stronger impact on insulin sensitivity than GLP-1 alone.

*Each order comes with syringes, alcohol pads, and bacteriostatic water*

*Shipping only available in the continental U.S.*

All products on this site are for research and development use only. Products are not for human consumption of any kind.